Ligand validation:4EXS

X8Z: L-CAPTOPRIL

X8Z is a Ligand Of Interest in 4EXS designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4EXS_X8Z_A_301	54%	48%	0.153	0.919	0.58	1.4	-	2	2	0	100%	1
4EXS_X8Z_B_301	31%	51%	0.246	0.918	0.85	1.05	-	1	0	0	100%	0.6
5ZIO_X8Z_A_303	76%	57%	0.138	0.976	0.76	0.91	-	-	0	0	100%	1
8SKO_X8Z_A_303	65%	51%	0.133	0.935	0.74	1.13	-	-	4	0	100%	0.8
9CV3_X8Z_A_304	87%	61%	0.087	0.96	0.79	0.69	1	-	0	0	100%	0.81
9CV5_X8Z_A_303	87%	57%	0.093	0.966	0.77	0.87	-	-	0	0	100%	0.9
2X8Z_X8Z_A_1615	82%	36%	0.111	0.966	1.32	1.22	2	1	0	0	100%	1
4C1H_X8Z_A_305	76%	17%	0.129	0.966	2.19	1.41	3	2	0	0	100%	0.7
4PQA_X8Z_A_401	75%	55%	0.117	0.95	0.64	1.07	-	1	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.